Novel Alliance Responds to Big Pharma's Most Pressing AI/ML Needs

Artificial intelligence and machine learning applications are not the future of drug development; they’re already here, being deployed at large pharmaceutical companies like Pfizer and Merck KGaA.

For big pharma to truly maximize AI/ML’s potential, however, better infrastructure is needed.

“If you ask people, 'What do you think drug discovery and development will look like 20 years from now?' Almost everybody gives you a very digital vision, [where] everything will be simulated,” said Yair Benita, Ph.D., chief technology officer at AION Labs. “Nobody says, ‘I'm going to have a huge lab with thousands of biologists.’